Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation

Centre Hospitalier Universitaire de Nice547 enrolled

Overview

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Study Type

OBSERVATIONAL

Enrollment

547

Conditions

Pulmonary Embolism

Interventions

no interventionOTHER

no intervention

Eligibility

Sex: ALLMin age: 18 YearsMax age: 110 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All pulmonary embolisms hospitalised in Nice hospital. * acceptation to enter in the cohorte survey Exclusion Criteria: \-

Locations (1)

Nice University Hospital

Nice, France

Outcomes

Primary Outcomes

Reccurence

number of patient with Documented symptomatic pulmonary embolism reccurence

Time frame: 10 years

Secondary Outcomes

Pulmonary hypertension

number of patients with Confirmed pulmonary hypertension after pulmonary embolism

Time frame: 10 years

Chronic pulmonary disease without hypertension

number of patients with dyspnea but without pulmonary hypertension, Documented non-reperfused pulmonary areas

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.